Skip to main content

Sign your next big deal

Inpart Deal is used by biotechs and top pharma companies to effectively track, manage, and report on deal activities, permitting more time to create strategic synergies beyond a single deal.

Request a demo

An end-to-end platform for all your partnering needs

Custom and prebuilt integrations

Easily add meetings from BIO Convention, J. P. Morgan Healthcare Conference or emails from your Outlook into the system. Import new data about opportunities from databases like Evaluate Pharma and more.

Centralized partnering data

Find everything you need to know about a potential partner or asset in one place, accessible at any time.
About Inpart Deal

Secure and accessible

Improve collaborations with secure file storage. Simply drag and drop documents and emails to securely store and share with stakeholders.
About Inpart Deal

Designed for biopharma BD

Consolidate all your opportunity and project data, report on progress and collaborate with your team.

“Inpart checked all the boxes. It's designed for biopharma business development, integrates with partnering conferences, and enables easy, professional reporting.”
Managing Partner at Shadow Lake Group

Connected to your ecosystem

Results from Inpart Connect campaigns are directly created in Inpart Deal without any manual data entry.

The system is also synced with over 20 of the biggest biopharma partnering conferences, including BIO Convention and J.P. Morgan so your meeting information can also be imported.

Learn more about Inpart Deal

Unify and centralize information

Store all discussions and data securely on the system, including details on leads, assets and related opportunities as well as meetings and conference follow-ups, emails, contracts, CDAs, and more.

About Inpart Deal
Asset ClassificationUnlinkAsset nameAPB-BS1Development phase and Clinical IndicationCandidate selection (In vitro activity/selectivity, in vivo efficacy, pk, safety, metabolism, manufacturability)Solid TumorNext MilestonesPreclinicalQ3 2023Assets typeNo asset typesMechanisms of ActionNo mechanisms of action for this assetRoutes of AdministrationNo routes of administration for this assetTargetsNo targets for this assetTechnologiesAntibody libraryAsset descripttionEffector molecule: Nectin4/PD-1 Indication: Solid CancerDatabaseInpart dataHide all5Elixirgen Scientific, Inc.NovatechMoleculareSee hidden profilesEvaluateShow all5Novacure ltd
Opportunities pipelineHide Declined20015010050IdentificationPre-CDA ReviewIn-licensing40302010Confidentia...Due DiligenceNegotiationContractingCompletedActiveOn-holdDeclinedClosed

Effectively track and report on your pipeline

Monitor and report on your pipeline within seconds. Instantly view the number of active opportunities at each stage, then with a single click, access all the details about those opportunities.

About Inpart Deal

Integrations for business development

Outlook Add-in

Securely store and share your emails

Use the platform to effortlessly store and share your emails with the Outlook Add-in, updating and retrieving information with just a few clicks.

Evaluate Pharma Profiles

Get the latest biopharma intelligence from Evaluate Pharma

Enrich your opportunities with the latest intelligence from Evaluate Pharma. Our algorithms will automatically match your opportunities to existing companies or assets in Evaluate Pharma. From there you can easily view the latest intelligence right from your opportunity. Select key data from Evaluate Pharma company and asset profiles are included for all Inpart Deal users with a manager role.

External Opportunity Portal

Capture external innovation opportunities

Manage scattered, unsolicited emails and submissions from your corporate website with Inpart's Opportunity Portal. It offers a simple, efficient way to build a repository of all external opportunities, sort through them and find the most interesting ones.

Inpart Data

Create opportunities with Inpart proprietary data

When initiating a new opportunity, rely on Inpart Data, our dedicated database for biotechs looking for investments or out-licensing. It automatically populates essential fields like company description, financial data, and asset development information. By connecting opportunities to Inpart Data, information will be automatically updated on company and asset profiles, ensuring access to the most recent information to make informed decisions.

Work together towards excellence

Inpart promotes collaboration between departments and empowers teams to make data-driven decisions.

“Inpart Deal provides clear insight into our activities and performance. We use it to analyze the evolution of our projects, prioritize our efforts, and communicate on our activities with the rest of the company.”
Search & Evaluation Director at Novo Nordisk

Manage your opportunities efficiently.

Empower your team with the right tool to accelerate and standardize the deal making process.

Request a demo

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use